Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Cancer Chemotherapy and Pharmacology
|
February 22, 2012
Safety, tolerability, and pharmacokinetics of amuvatinib from three phase 1 clinical studies in healthy volunteers
Gavin Choy, Rajashree Joshi-Hangal, Aram Oganesian, et al.
Molecular Cancer Therapeutics
|
May 6, 2010
S110, a 5-Aza-2'-deoxycytidine-containing dinucleotide, is an effective DNA methylation inhibitor in vivo and can reduce tumor growth
Jody C Chuang, Steven L Warner, David Vollmer, et al.
Molecular Cancer Therapeutics
|
October 15, 2009
Pharmacologic inhibition of Pim kinases alters prostate cancer cell growth and resensitizes chemoresistant cells to taxanes
Shannon M Mumenthaler, Patricia Y B Ng, Amanda Hodge, et al.
American Journal of Hematology
|
August 19, 2007
Oral decitabine reactivates expression of the methylated gamma-globin gene in Papio anubis
Donald Lavelle, Janet Chin, Kestis Vaitkus, et al.
Journal of Hematology & Oncology
|
October 15, 2016
Erratum to: Targeting MET kinase with the small-molecule inhibitor amuvatinib induces cytotoxicity in primary myeloma cells and cell lines
Cornel Joseph Phillip, Shadia Zaman, Shujun Shentu, et al.
Journal of Translational Medicine
|
October 12, 2010
S110, a novel decitabine dinucleotide, increases fetal hemoglobin levels in baboons (P. anubis)
Donald Lavelle, Yogen Saunthararajah, Kestis Vaitkus, et al.
Journal of Hematology & Oncology
|
December 12, 2013
Targeting MET kinase with the small-molecule inhibitor amuvatinib induces cytotoxicity in primary myeloma cells and cell lines
Cornel Joseph Phillip, Shadia Zaman, Shujun Shentu, et al.
Cancer Chemotherapy and Pharmacology
|
May 23, 2014
Phase 1B study of amuvatinib in combination with five standard cancer therapies in adults with advanced solid tumors
Monica Mita, Michael Gordon, Lee Rosen, et al.
Journal of Medicinal Chemistry
|
February 14, 2014
Design, synthesis, and pharmacological evaluation of fluorinated tetrahydrouridine derivatives as inhibitors of cytidine deaminase
Dana Ferraris, Bridget Duvall, Greg Delahanty, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Cancer Chemotherapy and Pharmacology
|
February 22, 2012
Safety, tolerability, and pharmacokinetics of amuvatinib from three phase 1 clinical studies in healthy volunteers
Gavin Choy, Rajashree Joshi-Hangal, Aram Oganesian, et al.
Molecular Cancer Therapeutics
|
May 6, 2010
S110, a 5-Aza-2'-deoxycytidine-containing dinucleotide, is an effective DNA methylation inhibitor in vivo and can reduce tumor growth
Jody C Chuang, Steven L Warner, David Vollmer, et al.
Molecular Cancer Therapeutics
|
October 15, 2009
Pharmacologic inhibition of Pim kinases alters prostate cancer cell growth and resensitizes chemoresistant cells to taxanes
Shannon M Mumenthaler, Patricia Y B Ng, Amanda Hodge, et al.
American Journal of Hematology
|
August 19, 2007
Oral decitabine reactivates expression of the methylated gamma-globin gene in Papio anubis
Donald Lavelle, Janet Chin, Kestis Vaitkus, et al.
Journal of Hematology & Oncology
|
October 15, 2016
Erratum to: Targeting MET kinase with the small-molecule inhibitor amuvatinib induces cytotoxicity in primary myeloma cells and cell lines
Cornel Joseph Phillip, Shadia Zaman, Shujun Shentu, et al.
Journal of Translational Medicine
|
October 12, 2010
S110, a novel decitabine dinucleotide, increases fetal hemoglobin levels in baboons (P. anubis)
Donald Lavelle, Yogen Saunthararajah, Kestis Vaitkus, et al.
Journal of Hematology & Oncology
|
December 12, 2013
Targeting MET kinase with the small-molecule inhibitor amuvatinib induces cytotoxicity in primary myeloma cells and cell lines
Cornel Joseph Phillip, Shadia Zaman, Shujun Shentu, et al.
Cancer Chemotherapy and Pharmacology
|
May 23, 2014
Phase 1B study of amuvatinib in combination with five standard cancer therapies in adults with advanced solid tumors
Monica Mita, Michael Gordon, Lee Rosen, et al.
Journal of Medicinal Chemistry
|
February 14, 2014
Design, synthesis, and pharmacological evaluation of fluorinated tetrahydrouridine derivatives as inhibitors of cytidine deaminase
Dana Ferraris, Bridget Duvall, Greg Delahanty, et al.
Page
of 2